drugset / Trial / NCT05331222
Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis
NaSingle-groupOpen-labelTreatment
Summary
Proof-of-concept study with a novel nasal spray in chronic rhinitis or chronic sinusitis. The study will involve 25 patients completing the study for a per protocol analysis.
Timeline
- Start
- 2022-09-30
- Primary completion
- 2023-03-03
- Completion
- 2023-03-03
Outcome
Outcome not reported
Stopped: “regulatory issues”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JT-1 | Unknown | 7 % | Intranasal |